Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

RCUSArcus Biosciences, Inc.

NYSE · CIK 0001724521
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts304

Identity from submissions API

NameArcus Biosciences, Inc.
CIK0001724521
TickersRCUS
ExchangesNYSE
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN473898435
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(510) 694-6200
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
3928 POINT EDEN WAY
HAYWARD
CA
94545
CA
Mailing address
3928 POINT EDEN WAY
HAYWARD
CA
94545
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

609 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-04 10-Q 10-Q 0001724521-26-000058 001-38419 261522277 34 7147498 1 1
2026-11-04 8-K 8-K 2.02,9.01 0001724521-26-000056 001-38419 261522216 34 326237 1 1
2026-10-23 8-K 8-K 8.01,9.01 0001724521-26-000050 001-38419 261482331 34 471352 1 1
2026-10-22 424B5 424B5 0001193125-26-428916 333-293750 261478914 33 932478 1 1
2026-10-21 424B5 424B5 0001193125-26-427888 333-293750 261476046 33 788636
2026-10-21 8-K 8-K 2.02 0001193125-26-427829 001-38419 261475793 34 136218 1 1
2026-10-20 8-K 8-K 8.01 0001724521-26-000047 001-38419 261470577 34 143248 1 1
2026-09-28 CT ORDER filename1.pdf 20260928,20260928 9999999997-26-001556 005-90423 261415894 34 106269
2026-08-24 4 FORM 4 0001771961-26-000006 8667
2026-08-21 144 xsl144X01/primary_doc.xml 0001950047-26-008535 001-38419 261305219 33 5398
2026-08-07 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-092737 005-90423 261254722 34 167800
2026-08-05 10-Q 10-Q 0001724521-26-000044 001-38419 261243620 34 6891022 1 1
2026-08-05 8-K 8-K 2.02,9.01 0001724521-26-000042 001-38419 261243477 34 339106 1 1
2026-07-13 4 FORM 4 0001422996-26-000006 10225
2026-07-09 144 xsl144X01/primary_doc.xml 0001958244-26-000445 001-38419 261166587 33 10018
2026-06-24 144 xsl144X01/primary_doc.xml 0001958244-26-000402 001-38419 261117079 33 16123
2026-06-24 4 xslF345X06/form4.xml 0001610717-26-000294 12194
2026-06-22 144 xsl144X01/primary_doc.xml 0001958244-26-000398 001-38419 261108363 33 8125
2026-06-12 4 FORM 4 0001770252-26-000003 7149
2026-06-12 4 FORM 4 0001311210-26-000003 7256
2026-06-12 4 FORM 4 0001277503-26-000003 9481
2026-06-12 4 FORM 4 0001836662-26-000005 7020
2026-06-12 4 FORM 4 0001734422-26-000005 7147
2026-06-12 4 FORM 4 0001206977-26-000009 8051
2026-06-12 4 FORM 4 0001792164-26-000006 7859
2026-06-12 4 FORM 4 0001201617-26-000003 7142
2026-06-12 8-K 8-K 5.07 0001724521-26-000037 001-38419 261086797 34 150846 1 1
2026-06-01 4 FORM 4 0001771961-26-000004 5662
2026-06-01 144 xsl144X01/primary_doc.xml 0001950047-26-005400 001-38419 261051274 33 4695
2026-05-12 4 FORM 4 0001792164-26-000003 5511
2026-05-12 4 FORM 4 0001653881-26-000005 4940
2026-05-11 144 xsl144X01/primary_doc.xml 0001628280-26-033690 001-38419 26964680 33 5269
2026-05-06 144 xsl144X01/primary_doc.xml 0001950047-26-004118 001-38419 26948484 33 6019
2026-05-05 10-Q 10-Q 0001724521-26-000034 001-38419 26943242 34 6370781 1 1
2026-05-05 8-K 8-K 2.02,9.01 0001724521-26-000032 001-38419 26943128 34 305010 1 1
2026-04-23 144 xsl144X01/primary_doc.xml 0001950047-26-003724 001-38419 26889345 33 5324
2026-04-21 ARS ARS 0001724521-26-000027 001-38419 26879498 34 19938545
2026-04-21 DEFA14A DEFA14A 0001724521-26-000026 001-38419 26879471 34 369838
2026-04-21 DEF 14A DEF 14A 0001724521-26-000025 001-38419 26879455 34 2297316 1 1
2026-04-20 8-K 8-K 8.01 0001724521-26-000021 001-38419 26873372 34 142427 1 1
2026-04-08 144 xsl144X01/primary_doc.xml 0001950047-26-003313 001-38419 26848373 33 4629
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000680 005-90423 26797813 34 7070
2026-03-23 8-K 8-K 5.02 0001724521-26-000014 001-38419 26779919 34 138822 1 1
2026-02-25 S-3ASR S-3ASR 0001193125-26-071862 333-293750 26679522 33 1245988 1 1
2026-02-25 S-8 S-8 0001724521-26-000011 333-293740 26678949 33 279555 1 1
2026-02-25 10-K 10-K 0001724521-26-000009 001-38419 26678659 34 11768914 1 1
2026-02-25 8-K 8-K 2.02,9.01 0001724521-26-000007 001-38419 26678561 34 321268 1 1
2026-01-26 4 FORM 4 0002056093-26-000002 7075
2026-01-26 4 FORM 4 0001182473-26-000005 7098
2026-01-26 4 FORM 4 0001422996-26-000004 7739
2026-01-26 4 FORM 4 0001836662-26-000002 7059
2026-01-26 4 FORM 4 0001653881-26-000002 7074
2026-01-26 4 FORM 4 0001771961-26-000002 7090
2026-01-26 4 FORM 4 0001671311-26-000002 7119
2026-01-09 4 FORM 4 0001182473-26-000003 4751
2026-01-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000038 005-90423 26518855 34 10971
2026-01-07 4 FORM 4 0001422996-26-000002 9579
2026-01-05 144 xsl144X01/primary_doc.xml 0001958244-26-000009 001-38419 26507405 33 11704
2026-01-02 4 xslF345X05/form4.xml 0001610717-26-000002 4379
2026-01-02 4 xslF345X05/form4.xml 0001610717-26-000001 4522
2025-12-31 144 xsl144X01/primary_doc.xml 0001628280-25-059249 001-38419 251618290 33 6688
2025-12-18 4 FORM 4 0001836662-25-000005 7760
2025-12-18 4 FORM 4 0002056093-25-000005 7944
2025-12-18 4 FORM 4 0001771961-25-000014 9757
2025-12-18 4 FORM 4 0001653881-25-000011 7595
2025-12-18 4 FORM 4 0001671311-25-000009 7639
2025-12-18 4 FORM 4 0001422996-25-000015 8259
2025-12-18 4 FORM 4 0001182473-25-000005 7844
2025-12-18 144 xsl144X01/primary_doc.xml 0001950047-25-010514 001-38419 251583384 33 6102
2025-12-18 8-K 8-K 1.01,2.03 0001724521-25-000122 001-38419 251583068 34 142791 1 1
2025-12-15 144 xsl144X01/primary_doc.xml 0002056093-25-000003 001-38419 251572854 33 4430
2025-12-15 144 xsl144X01/primary_doc.xml 0001836662-25-000003 001-38419 251572851 33 6157
2025-12-15 144 xsl144X01/primary_doc.xml 0001771961-25-000011 001-38419 251572849 33 7940
2025-12-15 144 xsl144X01/primary_doc.xml 0001653881-25-000009 001-38419 251572845 33 7351
2025-12-15 144 xsl144X01/primary_doc.xml 0001671311-25-000007 001-38419 251572841 33 7988
2025-12-15 144 xsl144X01/primary_doc.xml 0001422996-25-000013 001-38419 251572838 33 10526
2025-12-15 144 xsl144X01/primary_doc.xml 0001182473-25-000003 001-38419 251572835 33 6259
2025-12-12 8-K 8-K 8.01 0001724521-25-000120 001-38419 251566636 34 143683 1 1
2025-12-05 4 FORM 4 0001422996-25-000011 5864
2025-12-04 144 xsl144X01/primary_doc.xml 0001958244-25-004517 001-38419 251550551 33 10098
2025-12-01 4 FORM 4 0001771961-25-000009 8341
2025-11-26 144 xsl144X01/primary_doc.xml 0001950047-25-009435 001-38419 251530560 33 6108
2025-11-26 4 FORM 4 0001653881-25-000007 4654
2025-11-26 144 xsl144X01/primary_doc.xml 0001628280-25-054135 001-38419 251529276 33 5450
2025-11-19 4 FORM 4 0001422996-25-000009 9963
2025-11-17 144 xsl144X01/primary_doc.xml 0001958244-25-004463 001-38419 251492350 33 9183
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-005004 005-90423 251485995 34 12072
2025-11-12 4 FORM 4 0001671311-25-000005 8804
2025-11-05 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001123292-25-000613 005-90423 251455176 34 9481
2025-11-03 4 FORM 4 0001422996-25-000007 5865
2025-11-03 8-K 8-K 8.01,9.01 0001193125-25-262589 001-38419 251444332 34 409694 1 1
2025-10-31 424B5 424B5 0001193125-25-260836 333-270132 251440833 33 953002 1 1
2025-10-30 144 xsl144X01/primary_doc.xml 0001958244-25-004423 001-38419 251437420 33 8486
2025-10-30 424B5 424B5 0001193125-25-258794 333-270132 251436809 33 816751
2025-10-30 4 FORM 4 0001422996-25-000005 12019
2025-10-29 4 FORM 4 0001653881-25-000005 4671
2025-10-28 144/A xsl144X01/primary_doc.xml 0001628280-25-046879 001-38419 251426371 33 4475
2025-10-28 144 xsl144X01/primary_doc.xml 0001628280-25-046836 001-38419 251425819 33 4213
2025-10-28 144 xsl144X01/primary_doc.xml 0001958244-25-004418 001-38419 251425774 33 5272
2025-10-28 10-Q 10-Q 0001724521-25-000116 001-38419 251424928 34 7188956 1 1
2025-10-28 8-K 8-K 2.02,9.01 0001724521-25-000114 001-38419 251424866 34 330602 1 1
2025-10-14 8-K 8-K 8.01 0001724521-25-000109 001-38419 251389961 34 148622 1 1
2025-10-08 4 FORM 4 0001671311-25-000003 14491
2025-10-06 144 xsl144X01/primary_doc.xml 0001968582-25-000981 001-38419 251377192 33 4495
2025-10-06 8-K 8-K 8.01 0001724521-25-000107 001-38419 251375948 34 191650 1 1
2025-09-30 4 FORM 4 0001771961-25-000006 4686
2025-09-29 144 xsl144X01/primary_doc.xml 0001950047-25-007554 001-38419 251356686 33 5397
2025-09-05 4 FORM 4 0001771961-25-000003 5394
2025-09-05 144 xsl144X01/primary_doc.xml 0001950047-25-006799 001-38419 251297041 33 4695
2025-08-06 10-Q 10-Q 0001724521-25-000101 001-38419 251189735 34 7346869 1 1
2025-08-06 8-K 8-K 2.02,9.01 0001724521-25-000099 001-38419 251189623 34 323295 1 1
2025-07-15 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001123292-25-000309 005-90423 251125981 34 10120
2025-06-12 4 FORM 4 0001724521-25-000092 17433
2025-06-12 4 FORM 4 0001724521-25-000091 18134
2025-06-12 4 FORM 4 0001724521-25-000090 17325
2025-06-12 4 FORM 4 0001724521-25-000089 18144
2025-06-12 4 FORM 4 0001724521-25-000088 17423
2025-06-12 4 FORM 4 0001724521-25-000087 19794
2025-06-12 4 FORM 4 0001724521-25-000086 17429
2025-06-12 8-K 8-K 5.07,8.01,9.01 0001724521-25-000078 001-38419 251043001 34 178277 1 1
2025-06-02 8-K 8-K 7.01,8.01 0001724521-25-000066 001-38419 251013206 34 144761 1 1
2025-05-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002303 005-90423 25941850 34 17012
2025-05-06 10-Q 10-Q 0001724521-25-000063 001-38419 25917390 34 7484815 1 1
2025-05-06 8-K 8-K 2.02,9.01 0001724521-25-000061 001-38419 25917316 34 346154 1 1
2025-04-22 ARS ARS 0001724521-25-000056 001-38419 25857882 34 19962512
2025-04-22 DEFA14A DEFA14A 0001724521-25-000054 001-38419 25857847 34 371598
2025-04-22 DEF 14A DEF 14A 0001724521-25-000052 001-38419 25857818 34 2492929 1 1
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001576419-25-000558 005-90423 25844550 34 10963
2025-03-05 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001123292-25-000115 005-90423 25712220 34 75763
2025-02-27 4 FORM 4 0001724521-25-000046 7261
2025-02-27 4 FORM 4 0001724521-25-000045 5022
2025-02-25 S-8 S-8 0001724521-25-000042 333-285205 25663517 33 295479 1 1
2025-02-25 10-K 10-K 0001724521-25-000040 001-38419 25663120 34 11874871 1 1
2025-02-25 8-K 8-K 2.02,9.01 0001724521-25-000039 001-38419 25663070 34 366657 1 1
2025-02-20 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001123292-25-000105 005-90423 25648051 34 57988
2025-02-20 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-003084 4670
2025-02-19 8-K 8-K 8.01,9.01 0001193125-25-029591 001-38419 25639903 34 449363 1 1
2025-02-18 424B5 424B5 0001193125-25-028669 333-270132 25635768 33 814719 1 1
2025-02-18 8-K 8-K 2.02,8.01 0001193125-25-028110 001-38419 25632660 34 164435 1 1
2025-02-11 4 FORM 4 0001724521-25-000032 6935
2025-02-11 3 FORM 3 0001724521-25-000031 9059
2025-02-10 3 FORM 3 0001724521-25-000026 9048
2025-02-06 8-K 8-K 5.02 0001724521-25-000024 001-38419 25598264 34 147376 1 1
2025-01-27 4 FORM 4 0001724521-25-000021 6922
2025-01-27 4 FORM 4 0001724521-25-000020 6959
2025-01-27 4 FORM 4 0001724521-25-000019 6509
2025-01-27 4 FORM 4 0001724521-25-000018 6979
2025-01-27 4 FORM 4 0001724521-25-000017 6974
2025-01-27 4 FORM 4 0001724521-25-000016 6950
2025-01-27 4 FORM 4 0001724521-25-000015 5797
2025-01-27 4 FORM 4 0001724521-25-000014 7600
2025-01-21 8-K 8-K 5.02 0001724521-25-000005 001-38419 25542620 34 147861 1 1
2025-01-03 4 FORM 4 0001724521-25-000002 4825
2024-12-31 144 xsl144X01/primary_doc.xml 0001971857-24-000915 001-38419 241593115 33 4311
2024-12-20 4 FORM 4 0001724521-24-000187 4696
2024-12-17 SC 13D/A SC 13D/A 0001193125-24-280681 005-90423 241557476 34 32985
2024-12-17 4 FORM 4 0001724521-24-000184 4817
2024-12-17 4 FORM 4 0001724521-24-000183 4760
2024-12-17 4 FORM 4 0001724521-24-000182 5217
2024-12-17 4 FORM 4 0001724521-24-000181 4803
2024-12-17 4 FORM 4 0001724521-24-000180 4812
2024-12-17 4 FORM 4 0001724521-24-000179 4790
2024-12-17 4 FORM 4 0001724521-24-000178 5438
2024-12-04 4 FORM 4 0001724521-24-000162 4873
2024-11-12 SC 13G/A filing.txt 0000315066-24-002635 005-90423 241444420 34 8247
2024-11-08 SC 13G/A us03969f1093_110824.txt 0002012383-24-004072 005-90423 241442091 34 13919
2024-11-06 10-Q 10-Q 0001724521-24-000160 001-38419 241431437 34 7978569 1 1
2024-11-06 8-K 8-K 2.02,9.01 0001724521-24-000159 001-38419 241431407 34 366659 1 1
2024-10-24 8-K 8-K 7.01,8.01 0001724521-24-000153 001-38419 241392738 34 157345 1 1
2024-10-23 SC 13G/A us03969f1093_102324.txt 0002012383-24-001809 005-90423 241389789 34 13907
2024-10-17 SC 13G/A Arcus_Biosciences_Inc.htm 0000093751-24-000804 005-90423 241376486 34 55943
2024-09-17 4 FORM 4 0001724521-24-000150 4817
2024-09-17 4 FORM 4 0001724521-24-000149 4979
2024-08-27 8-K 8-K 1.01,2.03 0001724521-24-000144 001-38419 241249146 34 160531 1 1
2024-08-15 4 FORM 4 0001724521-24-000141 4875
2024-08-08 10-Q 10-Q 0001724521-24-000138 001-38419 241188535 34 6749968 1 1
2024-08-08 8-K 8-K 2.02,9.01 0001724521-24-000136 001-38419 241188335 34 364655 1 1
2024-06-18 4 FORM 4 0001724521-24-000129 4796
2024-06-18 4 FORM 4 0001724521-24-000128 5437
2024-06-18 4 FORM 4 0001724521-24-000127 4991
2024-06-18 4 FORM 4 0001724521-24-000126 4933
2024-06-07 4 FORM 4 0001724521-24-000116 9087
2024-06-07 4 FORM 4 0001724521-24-000115 6999
2024-06-07 4 FORM 4 0001724521-24-000114 7739
2024-06-07 4 FORM 4 0001724521-24-000113 7108
2024-06-07 4 FORM 4 0001724521-24-000112 6994
2024-06-07 4 FORM 4 0001724521-24-000111 7711
2024-06-07 4 FORM 4 0001724521-24-000110 7001
2024-06-06 8-K 8-K 5.07,8.01,9.01 0001724521-24-000101 001-38419 241025870 34 183615 1 1
2024-06-03 8-K 8-K 7.01,8.01 0001724521-24-000099 001-38419 241012067 34 169797 1 1
2024-05-23 8-K 8-K 8.01,9.01 0001724521-24-000096 001-38419 24979368 34 185901 1 1
2024-05-08 10-Q 10-Q 0001724521-24-000092 001-38419 24926034 34 6913827 1 1
2024-05-08 8-K 8-K 2.02,9.01 0001724521-24-000090 001-38419 24925810 34 344517 1 1
2024-04-24 ARS ARS 0001724521-24-000083 001-38419 24866484 34 16443609
2024-04-23 DEFA14A DEFA14A 0001724521-24-000081 001-38419 24864916 34 361402
2024-04-23 DEF 14A DEF 14A 0001724521-24-000079 001-38419 24864891 34 2512580 1 1
2024-03-29 4 FORM 4 0001724521-24-000071 5251
2024-03-27 144 xsl144X01/primary_doc.xml 0001968582-24-000263 001-38419 24790744 33 6915
2024-03-20 4 FORM 4 0001724521-24-000068 7456
2024-03-15 144 xsl144X01/primary_doc.xml 0001724521-24-000065 001-38419 24755264 33 7615
2024-02-28 4 FORM 4 0001724521-24-000063 7182
2024-02-28 4 FORM 4 0001724521-24-000062 7917
2024-02-23 4/A FORM 4/A 0001724521-24-000057 4987
2024-02-21 S-3ASR S-3ASR 0001193125-24-041550 333-277224 24660580 33 279012
2024-02-21 S-8 S-8 0001724521-24-000054 333-277219 24660164 33 139331
2024-02-21 10-K 10-K 0001724521-24-000052 001-38419 24659692 34 10836206 1 1
2024-02-21 8-K 8-K 2.02,9.01 0001724521-24-000050 001-38419 24659465 34 368527 1 1
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020321 005-90423 24627382 34 12995
2024-02-09 SC 13G filing.txt 0000315066-24-000970 005-90423 24611371 34 8068
2024-02-07 3 FORM 3 0001724521-24-000038 8982
2024-01-31 4 OWNERSHIP DOCUMENT 0001104659-24-008868 4893
2024-01-31 SC 13D/A SC 13D/A 0001104659-24-008866 005-90423 24583755 34 470486
2024-01-30 8-K 8-K 1.01,3.02,5.02,8.01,9.01 0001724521-24-000034 001-38419 24575943 34 258813 1 1
2024-01-25 4 FORM 4 0001724521-24-000030 6971
2024-01-25 4 FORM 4 0001724521-24-000029 6913
2024-01-25 4 FORM 4 0001724521-24-000028 6946
2024-01-25 4 FORM 4 0001724521-24-000027 6922
2024-01-25 4 FORM 4 0001724521-24-000026 6959
2024-01-25 4 FORM 4 0001724521-24-000025 6979
2024-01-25 4 FORM 4 0001724521-24-000024 6966
2024-01-24 SC 13G Arcus_Bioscience.txt 0000093751-24-000108 005-90423 24554241 34 8442
2024-01-23 SC 13G/A us03969f1093_012324.txt 0001086364-24-001338 005-90423 24551309 34 13617
2024-01-04 4 FORM 4 0001724521-24-000009 4825
2024-01-04 4 FORM 4 0001724521-24-000008 5874
2024-01-04 144/A xsl144X01/primary_doc.xml 0001958244-24-000015 001-38419 24512009 33 6831
2024-01-02 144 xsl144X01/primary_doc.xml 0001971857-24-000013 001-38419 24503722 33 4822
2024-01-02 4 FORM 4 0001724521-24-000003 4475
2024-01-02 144 xsl144X01/primary_doc.xml 0001958244-24-000011 001-38419 24503501 33 5202
2023-12-26 4 FORM 4 0001724521-23-000076 5252
2023-12-22 144 xsl144X01/primary_doc.xml 0001968582-23-000845 001-38419 231510093 33 7111
2023-12-22 4 FORM 4 0001724521-23-000073 4694
2023-12-20 4 FORM 4 0001724521-23-000070 7571
2023-12-20 4 FORM 4 0001724521-23-000069 7617
2023-12-20 4 FORM 4 0001724521-23-000068 7427
2023-12-20 4 FORM 4 0001724521-23-000067 7450
2023-12-20 4 FORM 4 0001724521-23-000066 7633
2023-12-20 4 FORM 4 0001724521-23-000065 8077
2023-12-20 4 FORM 4 0001724521-23-000064 7438
2023-12-15 144 xsl144X01/primary_doc.xml 0001724521-23-000042 001-38419 231490668 33 5504
2023-12-15 144 xsl144X01/primary_doc.xml 0001724521-23-000040 001-38419 231490641 33 4985
2023-12-15 144 xsl144X01/primary_doc.xml 0001724521-23-000038 001-38419 231490609 33 5561
2023-12-15 144 xsl144X01/primary_doc.xml 0001724521-23-000036 001-38419 231490587 33 6876
2023-12-15 144 xsl144X01/primary_doc.xml 0001724521-23-000034 001-38419 231490552 33 5562
2023-12-15 144 xsl144X01/primary_doc.xml 0001724521-23-000032 001-38419 231490508 33 5598
2023-12-05 4 FORM 4 0001724521-23-000024 4793
2023-11-07 10-Q 10-Q 0001724521-23-000021 001-38419 231384040 34 6626620 1 1
2023-11-07 8-K 8-K 2.02,9.01 0001724521-23-000018 001-38419 231383612 34 362880 1 1
2023-09-26 4 FORM 4 0001724521-23-000011 5170
2023-09-22 144 xsl144X01/primary_doc.xml 0001968582-23-000533 001-38419 231271901 33 8164
2023-09-20 4 FORM 4 0001724521-23-000008 5081
2023-09-20 4 FORM 4 0001724521-23-000006 4921
2023-09-15 144 xsl144X01/primary_doc.xml 0001628280-23-032390 001-38419 231259299 33 4386
2023-09-15 144 xsl144X01/primary_doc.xml 0001628280-23-032387 001-38419 231259270 33 6361
2023-08-07 10-Q 10-Q 0000950170-23-038760 001-38419 231145729 34 9615693 1 1
2023-08-07 8-K 8-K 2.02,9.01 0000950170-23-038757 001-38419 231145720 34 604991 1 1
2023-07-31 4 FORM 4 SUBMISSION 0001209191-23-043821 5286
2023-07-06 SC 13D/A SC 13D/A 0001104659-23-078512 005-90423 231072276 34 274747
2023-07-05 4 FORM 4 SUBMISSION 0001209191-23-040964 4732
2023-06-30 4 OWNERSHIP DOCUMENT 0001104659-23-077015 4796
2023-06-28 8-K 8-K 1.01,3.02 0000950170-23-030273 001-38419 231049315 34 162351 1 1
2023-06-26 4 FORM 4 SUBMISSION 0001209191-23-039718 5286
2023-06-22 144 xsl144X01/primary_doc.xml 0001968582-23-000275 001-38419 231033395 33 5933
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-038160 5678
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-038157 5735
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-038154 7901
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-038152 5737
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-038150 7236
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-038148 7211
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-038145 7243
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-038144 7955
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-038142 7352
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-038141 9575
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-038139 9616
2023-06-16 8-K 8-K 5.07,8.01,9.01 0000950170-23-028621 001-38419 231021422 34 234176 1 1
2023-06-15 144 xsl144X01/primary_doc.xml 0000950170-23-028297 001-38419 231017605 33 4221
2023-06-15 144 xsl144X01/primary_doc.xml 0000950170-23-028296 001-38419 231017590 33 4957
2023-06-15 144 xsl144X01/primary_doc.xml 0000950170-23-028292 001-38419 231017530 33 4271
2023-06-15 144 xsl144X01/primary_doc.xml 0000950170-23-028286 001-38419 231017462 33 4304
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035740 5276
2023-06-07 144 xsl144X01/primary_doc.xml 0001971857-23-000220 001-38419 23998583 33 4717
2023-06-05 8-K 8-K 7.01,8.01 0000950170-23-026241 001-38419 23991303 34 216964 1 1
2023-05-15 8-K 8-K 1.01 0000950170-23-021988 001-38419 23918630 34 161388 1 1
2023-05-09 10-Q 10-Q 0000950170-23-019695 001-38419 23902224 34 8008101 1 1
2023-05-09 8-K 8-K 2.02,9.01 0000950170-23-019659 001-38419 23902058 34 499618 1 1
2023-04-25 ARS ARS 0000950170-23-014445 001-38419 23845160 34 1209080
2023-04-21 DEFA14A DEFA14A 0000950170-23-013844 001-38419 23836492 34 373756
2023-04-21 DEF 14A DEF 14A 0000950170-23-013840 001-38419 23836438 34 4037894 1 1
2023-03-20 4 FORM 4 SUBMISSION 0001209191-23-020037 5565
2023-03-10 3 FORM 3 SUBMISSION 0001209191-23-017833 15242
2023-03-10 8-K 8-K 5.02 0000950170-23-007320 001-38419 23724355 34 164313 1 1
2023-02-28 S-3ASR S-3ASR 0001193125-23-054100 333-270132 23687016 33 1089110
2023-02-28 S-8 S-8 0000950170-23-005155 333-270114 23686223 33 286428
2023-02-28 10-K 10-K 0000950170-23-005112 001-38419 23685664 34 16195452 1 1
2023-02-28 8-K 8-K 2.02,9.01 0000950170-23-005084 001-38419 23685332 34 617316 1 1
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021577 005-90423 23628972 34 108839
2023-02-14 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-23-000534 005-90423 23625145 34 276853
2023-02-10 SC 13G/A rcus13ga.htm 0000935836-23-000088 005-90423 23607585 34 46861
2023-02-09 SC 13G SCHEDULE 13G 0001104659-23-015346 005-90423 23602446 34 12884
2023-01-30 4 FORM 4 SUBMISSION 0001209191-23-005513 7313
2023-01-26 SC 13G/A us03969f1093_012623.txt 0001306550-23-004065 005-90423 23554242 34 13206
2023-01-25 4 FORM 4 SUBMISSION 0001209191-23-004876 7149
2023-01-25 4 FORM 4 SUBMISSION 0001209191-23-004875 7184
2023-01-25 4 FORM 4 SUBMISSION 0001209191-23-004874 7131
2023-01-25 4 FORM 4 SUBMISSION 0001209191-23-004873 7189
2023-01-25 4 FORM 4 SUBMISSION 0001209191-23-004872 7810
2023-01-25 4 FORM 4 SUBMISSION 0001209191-23-004870 7872
2023-01-20 SC 13G/A us03969f1093_011923.txt 0001306550-23-000622 005-90423 23539216 34 13182
2022-12-19 8-K 8-K 8.01 0000950170-22-026760 001-38419 221471913 34 186453 1 1
2022-12-16 4 FORM 4 SUBMISSION 0001209191-22-061762 7618
2022-12-16 4 FORM 4 SUBMISSION 0001209191-22-061761 7565
2022-12-16 4 FORM 4 SUBMISSION 0001209191-22-061760 7801
2022-12-16 4 FORM 4 SUBMISSION 0001209191-22-061759 8245
2022-12-16 4 FORM 4 SUBMISSION 0001209191-22-061758 8308
2022-11-28 8-K 8-K 8.01 0000950170-22-025712 001-38419 221421174 34 161670 1 1
2022-11-02 10-Q 10-Q 0000950170-22-021241 001-38419 221354188 34 10611466 1 1
2022-11-02 8-K 8-K 2.02,9.01 0000950170-22-021219 001-38419 221353970 34 585705 1 1
2022-10-17 SC 13G SC 13G 0001104659-22-109315 005-90423 221313791 34 125880
2022-10-11 S-3ASR S-3ASR 0001193125-22-260690 333-267822 221304584 33 270932
2022-10-11 8-K 8-K 1.01,9.01 0001193125-22-260620 001-38419 221304214 34 154141 1 1
2022-09-20 4 FORM 4 SUBMISSION 0001209191-22-050704 5535
2022-08-24 4 FORM 4 SUBMISSION 0001209191-22-047316 7145
2022-08-08 3 FORM 3 SUBMISSION 0001209191-22-044783 5954
2022-08-03 10-Q 10-Q 0000950170-22-014280 001-38419 221132971 34 9643762 1 1
2022-08-03 8-K 8-K 2.02,9.01 0000950170-22-014263 001-38419 221132833 34 572367 1 1
2022-06-21 4 FORM 4 SUBMISSION 0001209191-22-038399 9830
2022-06-21 4 FORM 4 SUBMISSION 0001209191-22-038396 10398
2022-06-21 4 FORM 4 SUBMISSION 0001209191-22-038390 9889
2022-06-21 4 FORM 4 SUBMISSION 0001209191-22-038386 10336
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037443 8101
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037438 7403
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037417 7498
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037414 7203
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037412 7389
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037409 9542
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037408 8125
2022-06-16 8-K 8-K 5.07,8.01,9.01 0000950170-22-011747 001-38419 221020728 34 258294 1 1
2022-06-07 UPLOAD filename1.pdf 0000000000-22-006159 39438
2022-06-03 CORRESP filename1.htm 0000950170-22-011156 92368
2022-05-10 UPLOAD filename1.pdf 0000000000-22-005134 44265
2022-05-09 10-Q 10-Q 0000950170-22-008502 001-38419 22905138 34 8333751 1 1
2022-05-09 8-K 8-K 2.02,9.01 0000950170-22-008484 001-38419 22904950 34 487355 1 1
2022-05-09 SC 13G us03969f1093_050922.txt 0000834237-22-009648 005-90423 22904540 34 13339
2022-04-20 DEFA14A DEFA14A 0000950170-22-005859 001-38419 22838210 34 236699
2022-04-20 DEF 14A DEF 14A 0000950170-22-005855 001-38419 22838161 34 1993798
2022-03-18 4 FORM 4 SUBMISSION 0001209191-22-020038 5009
2022-03-14 SC 13G THE SCHEDULE 13G 0000921895-22-000856 005-90423 22737247 34 285182
2022-03-10 4 FORM 4 SUBMISSION 0001209191-22-017989 7123
2022-03-10 4 FORM 4 SUBMISSION 0001209191-22-017984 7176
2022-03-10 4 FORM 4 SUBMISSION 0001209191-22-017979 7184
2022-03-10 4 FORM 4 SUBMISSION 0001209191-22-017973 7805
2022-03-10 4 FORM 4 SUBMISSION 0001209191-22-017967 10216
2022-03-02 4 FORM 4 SUBMISSION 0001209191-22-014850 5308
2022-02-23 S-8 S-8 0001564590-22-006304 333-262929 22664582 33 247983
2022-02-23 10-K 10-K 0000950170-22-001788 001-38419 22663890 34 15584320 1 1
2022-02-23 8-K 8-K 2.02,9.01 0000950170-22-001777 001-38419 22663595 34 543580 1 1
2022-02-14 SC 13G/A arcusbiosciences13ga.htm 0000935836-22-000173 005-90423 22631183 34 47194
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-022225 005-90423 22628204 34 114442
2022-02-14 SC 13G/A SC 13G/A 0001193125-22-040721 005-90423 22628115 34 196584
2022-02-04 SC 13G us03969f1093_020422.txt 0000834237-22-007136 005-90423 22593342 34 13368
2021-12-22 4 FORM 4 SUBMISSION 0001209191-21-070958 9408
2021-12-21 8-K 8-K 8.01 0000950170-21-005305 001-38419 211509936 34 156462 1 1
2021-12-20 4 FORM 4 SUBMISSION 0001209191-21-070568 16105
2021-12-20 4 FORM 4 SUBMISSION 0001209191-21-070565 15978
2021-12-20 4 FORM 4 SUBMISSION 0001209191-21-070563 16616
2021-12-20 4 FORM 4 SUBMISSION 0001209191-21-070560 16176
2021-12-20 4 FORM 4 SUBMISSION 0001209191-21-070557 17376
2021-11-18 8-K 8-K 1.01 0000950170-21-004749 001-38419 211422590 34 161770 1 1
2021-11-08 8-K 8-K 2.02,9.01 0000950170-21-003506 001-38419 211388870 34 544303 1 1
2021-11-08 10-Q 10-Q 0000950170-21-003471 001-38419 211388186 34 9327658 1 1
2021-09-22 4 FORM 4 SUBMISSION 0001209191-21-057262 13518
2021-08-13 3 FORM 3 SUBMISSION 0001209191-21-051435 5916
2021-08-11 8-K 8-K 5.02 0001564590-21-043472 001-38419 211163900 34 155921 1 1
2021-08-05 4 FORM 4 SUBMISSION 0001209191-21-049938 7111
2021-08-05 3 FORM 3 SUBMISSION 0001209191-21-049934 5894
2021-08-05 10-Q 10-Q 0001564590-21-041611 001-38419 211148501 34 8314797 1 1
2021-08-05 8-K 8-K 2.02,5.02,9.01 0001564590-21-041591 001-38419 211148324 34 467452 1 1
2021-07-19 SC 13G arcus13g.htm 0000935836-21-000427 005-90423 211098640 34 46835
2021-07-19 8-K 8-K 5.02,7.01,9.01 0001564590-21-037042 001-38419 211098378 34 178244 1 1
2021-06-21 4 FORM 4 SUBMISSION 0001209191-21-042082 9830
2021-06-21 4 FORM 4 SUBMISSION 0001209191-21-042080 11095
2021-06-21 4 FORM 4 SUBMISSION 0001209191-21-042077 9716
2021-06-21 4 FORM 4 SUBMISSION 0001209191-21-042075 10336
2021-06-21 4 FORM 4 SUBMISSION 0001209191-21-042074 9900
2021-06-07 4 FORM 4 SUBMISSION 0001209191-21-038651 5184
2021-06-07 4 FORM 4 SUBMISSION 0001209191-21-038639 8144
2021-06-07 4 FORM 4 SUBMISSION 0001209191-21-038635 7216
2021-06-07 4 FORM 4 SUBMISSION 0001209191-21-038628 7540
2021-06-07 4 FORM 4 SUBMISSION 0001209191-21-038623 7253
2021-06-07 4 FORM 4 SUBMISSION 0001209191-21-038619 9788
2021-06-07 4 FORM 4 SUBMISSION 0001209191-21-038616 8171
2021-06-07 8-K 8-K 5.07,8.01,9.01 0001564590-21-031965 001-38419 21999827 34 219508 1 1
2021-05-05 10-Q 10-Q 0001564590-21-024084 001-38419 21893602 34 7213997 1 1
2021-05-05 8-K 8-K 2.02,9.01 0001564590-21-024065 001-38419 21893390 34 382711 1 1
2021-04-26 8-K 8-K 7.01 0001564590-21-020541 001-38419 21854144 34 156033 1 1
2021-04-26 4 FORM 4 - 0001179110-21-004605 7069
2021-04-26 4 FORM 4 - 0001179110-21-004603 4806
2021-04-20 DEFA14A DEFA14A 0001564590-21-019634 001-38419 21837987 34 1239380
2021-04-20 DEF 14A DEF 14A 0001564590-21-019630 001-38419 21837942 34 1836622
2021-04-19 8-K 8-K 3.01 0001564590-21-019230 001-38419 21832680 34 155630 1 1
2021-04-02 4 FORM 4 SUBMISSION 0001209191-21-024405 5673

Latest XBRL company facts

One latest value per concept from companyfacts (304 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 143.99M 2026-10-29 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
dei EntityPublicFloat Entity Public Float USD 565.88M 2025-06-30 2025 FY 10-K 2026-02-25 0001724521-26-000009
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 6.04M 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001724521-26-000025
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.55M 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001724521-26-000025
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 87.6 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001724521-26-000025
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 17.73M 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001724521-26-000025
ecd PeoTotalCompAmt PeoTotalCompAmt USD 9.66M 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001724521-26-000025
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 89.87 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001724521-26-000025
ffd NetFeeAmt NetFeeAmt USD 25,012.5 2026-10-21 424B5 2026-10-22 0001193125-26-428916
ffd NrrtvMaxAggtOfferingPric NrrtvMaxAggtOfferingPric USD 287.50M 2026-10-21 424B5 2026-10-22 0001193125-26-428916
ffd TtlFeeAmt TtlFeeAmt USD 25,012.5 2026-10-21 424B5 2026-10-22 0001193125-26-428916
ffd TtlOfferingAmt TtlOfferingAmt USD 287.50M 2026-10-21 424B5 2026-10-22 0001193125-26-428916
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-21 424B5 2026-10-22 0001193125-26-428916
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-10-21 424B5 2026-10-22 0001193125-26-428916
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 44.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap AccountsReceivableRelatedPartiesCurrent Accounts Receivable, Related Parties, Current USD 32.00M 2023-06-30 2023 Q2 10-Q 2023-08-07 0000950170-23-038760
us-gaap AccountsReceivableRelatedPartiesNoncurrent Accounts Receivable, Related Parties, Noncurrent USD 1.86M 2022-09-30 2022 Q3 10-Q 2022-11-02 0000950170-22-021241
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 7.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 3.00M 2023-09-30 2023 Q3 10-Q 2023-11-07 0001724521-23-000021
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 20.53M 2022-09-30 2022 Q3 10-Q 2022-11-02 0000950170-22-021241
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 457,000 2022-09-30 2022 Q3 10-Q 2022-11-02 0000950170-22-021241
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 50.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -2.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.18B 2022-09-30 2022 Q3 10-Q 2022-11-02 0000950170-22-021241
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 16.00M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 21.63M 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-23 0000950170-22-001788
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 50.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 21.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap AreaOfLand Area of Land sqft 14,500 2022-04-30 2022 FY 10-K 2023-02-28 0000950170-23-005112
us-gaap Assets Assets USD 818.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap AssetsCurrent Assets, Current USD 664.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 694.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 2.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 696.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 743.37M 2021-09-30 2021 Q3 10-Q 2021-11-08 0000950170-21-003471
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 62,000 2021-09-30 2021 Q3 10-Q 2021-11-08 0000950170-21-003471
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 154,000 2021-09-30 2021 Q3 10-Q 2021-11-08 0000950170-21-003471
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 743.46M 2021-09-30 2021 Q3 10-Q 2021-11-08 0000950170-21-003471
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 345.21M 2021-09-30 2021 Q3 10-Q 2021-11-08 0000950170-21-003471
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 694.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 479.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 64.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap AvailableForSaleSecuritiesGrossRealizedGainLossNet Available-for-sale Securities, Gross Realized Gain (Loss) USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-08 0000950170-21-003471
us-gaap AvailableForSaleSecuritiesNoncurrent Available-for-sale Securities, Noncurrent USD 218.73M 2021-09-30 2021 Q3 10-Q 2021-11-08 0000950170-21-003471
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap CapitalizedContractCostAmortization Capitalized Contract Cost, Amortization USD 2.00M 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-06 0001724521-25-000063
us-gaap CapitalLeasesFutureMinimumSubleaseRentals Capital Leases, Future Minimum Sublease Rentals USD 100,000 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008972
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 151.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 151.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -27.36M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-05 0001564590-19-006274
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 154.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -71.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 8.31M 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008972
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 400.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 127.60M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 127.60M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap CommonStockValue Common Stock, Value, Issued USD 2.19B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -349.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap ContractWithCustomerAssetNet Contract with Customer, Asset, after Allowance for Credit Loss USD 3.00M 2025-03-31 2025 Q1 10-Q 2025-05-06 0001724521-25-000063
us-gaap ContractWithCustomerAssetNetCurrent Contract with Customer, Asset, after Allowance for Credit Loss, Current USD 18.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 48.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 14.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 34.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 61.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap CostsAndExpensesRelatedParty Costs and Expenses, Related Party USD 3.76M 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-23 0000950170-22-001788
us-gaap CurrentFederalStateAndLocalTaxExpenseBenefit Current Federal, State and Local, Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 100.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.13 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD -2.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-02 0001564590-19-015333
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 300,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-02 0000950170-22-021241
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions position 128 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 13.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 3.60M 2018-03-31 2018 FY 10-K 2019-03-05 0001564590-19-006274
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 3.73M 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008270
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 7.00M 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008972
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 12.02M 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008972
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 142.00M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-08 0001724521-24-000092
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 19.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 425.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 39.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 7.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 59.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 26.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 412.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 4.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 1 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-23 0000950170-22-001788
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 7.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 2.70M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028583
us-gaap Dividends Dividends USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-05 0001564590-19-006274
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 83,000 2018-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008972
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.74 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.88 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-03 0000950170-22-014280
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.74 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.261 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.163 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-05 0001564590-19-006274
us-gaap EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Percent pure -0.041 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-25 0001724521-25-000040
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.009 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008270
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.014 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0.031 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008270
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.011 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.042 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 28.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 23.70M 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008972
us-gaap EquityMethodInvestments Equity Method Investments USD 1.20M 2018-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008972
us-gaap EquitySecuritiesFvNiRealizedGainLoss Equity Securities, FV-NI, Realized Gain (Loss) USD 613,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-23 0000950170-22-001788
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2021-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-041611
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2021-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-041611
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2021-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-041611
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2021-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-041611
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-041611
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-041611
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-041611
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-041611
us-gaap GainLossOnSaleOfEquityInvestments Gain (Loss) on Sale of Equity Investments USD 613,000 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-08 0000950170-21-003471
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 76.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-23 0000950170-22-001788
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -353.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -347.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -1.88 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-03 0000950170-22-014280
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -4.15 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-21 0001724521-24-000052
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -4.15 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-21 0001724521-24-000052
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD -613,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-23 0000950170-22-001788
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 92.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -74.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 5.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 4.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 15.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 2.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 2.48M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001564590-20-051355
us-gaap IncreaseDecreaseInContractWithCustomerAsset Increase (Decrease) in Contract with Customer, Asset USD -23.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -63.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -2.00M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008972
us-gaap IncreaseDecreaseInDueFromRelatedPartiesCurrent Increase (Decrease) in Due from Related Parties, Current USD -83,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-23 0000950170-22-001788
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD -4.13M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-02 0000950170-22-021241
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD 57,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-23 0000950170-22-001788
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -20.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.15M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-02 0000950170-22-021241
us-gaap IncrementalCommonSharesAttributableToContingentlyIssuableShares Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares shares 7,588 2020-07-01 2020-09-30 2021 Q3 10-Q 2021-11-08 0000950170-21-003471
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-05 0001724521-26-000044
us-gaap InterestExpenseDebt Interest Expense, Debt USD 10.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 9.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 7.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap InvestmentsAndCash Investments and Cash USD 694.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 116.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 22.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 18.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 20.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 19.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 19.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 18.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.16M 2021-09-30 2021 Q3 10-Q 2021-11-08 0000950170-21-003471
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 17.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap Liabilities Liabilities USD 695.12M 2022-09-30 2022 Q3 10-Q 2022-11-02 0000950170-22-021241
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 818.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap LiabilitiesCurrent Liabilities, Current USD 199.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap LicenseAndServicesRevenue License and Services Revenue (Deprecated 2018-01-31) USD 1.25M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012447
us-gaap LongTermDebt Long-term Debt USD 102.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 26.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 129.43M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012447
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 248.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -16.49M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012447
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -345.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -347.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 14.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap OperatingExpenses Operating Expenses USD 428.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -361.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap OperatingLeaseCost Operating Lease, Cost USD 17.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 99.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 14.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 86.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.47M 2021-04-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0000950170-22-008502
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 58.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 6.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 90.30M 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008270
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 2.10M 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008270
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 2.42M 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008270
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 2.34M 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008270
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 2.27M 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008270
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 2.19M 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008270
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 1.60M 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-23 0000950170-22-001788
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.052 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 253.30M 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008270
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 24.18M 2021-12-31 2021 FY 10-K 2022-02-23 0000950170-22-001788
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 57.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -1.00M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -2.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 141.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 125.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 177,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008270
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD 3.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap OtherSundryLiabilitiesCurrent Other Sundry Liabilities, Current USD 11.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-25 0001724521-25-000040
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 94,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008972
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 135,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008270
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-21 0001724521-24-000052
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 1.09B 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-02 0000950170-22-021241
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 463.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2023-09-30 2023 Q3 10-Q 2023-11-07 0001724521-23-000021
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2023-09-30 2023 Q3 10-Q 2023-11-07 0001724521-23-000021
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 16.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 125.11M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008270
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-05 0001564590-19-006274
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 26.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 490.86M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-02 0000950170-22-021241
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 1.00M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008270
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -347.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 90.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 33.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap ProvisionForLoanLossesExpensed Financing Receivable, Credit Loss, Expense (Reversal) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD 0 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-02 0000950170-22-021241
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 352.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 3.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.83B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer USD 24.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 43.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 15.42M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-041611
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 256.00M 2025-06-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap Revenues Revenues USD 67.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-25 0001724521-25-000040
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 150.00M 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 13.60M 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 11 2025-03-31 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap SecurityDeposit Security Deposit USD 3.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 50.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 372,774 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008972
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-23 0000950170-22-001788
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 3.80M 2018-12-31 2018 FY 10-K 2019-03-05 0001564590-19-006274
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 77.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 12.40M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 20.24 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 4.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 1.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 22.27 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 3.39M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-05 0001564590-19-040421
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 3.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 22.05 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-23 0000950170-22-001788
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 118.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 16.90M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 18.79 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 118.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 16.90M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 18.79 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 48.00M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-005112
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 37,250 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-23 0000950170-22-001788
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 11.6 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 12.75 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 300,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-23 0000950170-22-001788
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 358.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.253 2018-03-07 2018-03-09 2019 FY 10-K 2020-03-05 0001564590-20-008972
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensation Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture shares 713,931 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028583
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 400,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 226.20M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008270
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 2.30M 2022-04-01 2022-06-30 2022 Q3 10-Q 2022-11-02 0000950170-22-021241
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 142.00M 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 188,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-23 0000950170-22-001788
us-gaap SubleaseIncome Sublease Income USD 100,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008270
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2018-12-31 2018 FY 10-K 2019-03-05 0001564590-19-006274
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 226.72M 2017-12-31 2018 FY 10-K 2019-03-05 0001564590-19-006274
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2018-12-31 2018 FY 10-K 2019-03-05 0001564590-19-006274
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2018-12-31 2018 FY 10-K 2019-03-05 0001564590-19-006274
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2018-12-31 2018 FY 10-K 2019-03-05 0001564590-19-006274
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2018-12-31 2018 FY 10-K 2019-03-05 0001564590-19-006274
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 24.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 5.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 1.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 1.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 96.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001724521-26-000009
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 126.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 71.51M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-03 0000950170-22-014280
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-21 0001724521-24-000052
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 125.70M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-05 0001724521-26-000044
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 126.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001724521-26-000058

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →